4 results
6-K
EX-99.1
IPA
ImmunoPrecise Antibodies Ltd
20 Oct 23
Current report (foreign)
2:56pm
director with knowledge of its business through the imposition of an arbitrary term limit.
- A7 -
11) POLICIES REGARDING THE REPRESENTATION OF WOMEN … ON THE BOARD
a) Disclose whether the issuer has adopted a written policy relating to the identification and nomination of women directors
6-K
EX-99.2
IPA
ImmunoPrecise Antibodies Ltd
17 Nov 22
Current report (foreign)
9:36am
business through the imposition of an arbitrary term limit.
- A7 -
11) POLICIES REGARDING THE REPRESENTATION OF WOMEN ON THE BOARD
a) Disclose whether … the issuer has adopted a written policy relating to the identification and nomination of women directors. If the issuer has not adopted such a policy
6-K
EX-99.2
IPA
ImmunoPrecise Antibodies Ltd
14 Apr 22
Current report (foreign)
10:18am
of 12 April 1965, the Belgian National Collective Bargaining Agreement n° 25 on equal pay between men and women, the Belgian Coordinated Act of 18 July
6-K
EX-99.1
IPA
ImmunoPrecise Antibodies Ltd
12 Nov 21
Current report (foreign)
8:58am
of a qualified director with knowledge of its business through the imposition of an arbitrary term limit.
POLICIES REGARDING THE REPRESENTATION OF WOMEN … ON THE BOARD
Disclose whether the issuer has adopted a written policy relating to the identification and nomination of women directors
- Prev
- 1
- Next